Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Adherium Ltd. ( (AU:ADR) ) has shared an update.
Adherium Ltd. announced the issuance of 223,791,917 unquoted equity securities, which are options expiring on July 31, 2026, with an exercise price of $0.005. This move is part of previously announced transactions and is not intended for quotation on the ASX, potentially impacting the company’s financial strategy and stakeholder interests by expanding its capital base.
More about Adherium Ltd.
Adherium Ltd. operates in the healthcare technology industry, focusing on the development and provision of digital health solutions. The company specializes in creating innovative products that enhance patient adherence to prescribed medications, primarily targeting respiratory conditions.
Technical Sentiment Signal: Sell
Current Market Cap: A$7.87M
For a thorough assessment of ADR stock, go to TipRanks’ Stock Analysis page.